Transaction #2516 · Form 4 · 0001031686-25-000004
Rani Therapeutics Holdings, Inc. · Purchase · Warrant to Purchase Class A Common Stock
Rani Therapeutics Holdings, Inc. · Transacted October 23, 2025 · Filed October 27, 2025
What does this filing report?
An SEC Form 4 filing for Rani Therapeutics Holdings, Inc. records a purchase involving Warrant to Purchase Class A Common Stock on October 23, 2025. The reported quantity was 2,083,334. The filing date is October 27, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001856725
- Security type
- Derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 2,083,334
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 2,083,334
- Ownership description
- Not reported
- SEC acceptance time
- Oct 27, 2025, 7:24 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- IMRAN MIR A ↗
Director · 10% owner
CIK 0001031686
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Class A Common Stock
- Underlying quantity
- 2,083,334
- Conversion / exercise price
- 0.48
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer.
- F2
- The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F3
- The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F4
- The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.